Skip to the page

Data / Drug companies / Teva Pharmaceuticals, Inc.

Teva Pharmaceuticals, Inc.: 176 products in the FDA NDC directory, labeler code 0480

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Teva Pharmaceuticals, Inc. (labeler code 0480) lists 176 products in the FDA National Drug Code Directory, covering 60 finished drugs by generic name. By type: 155 prescription drugs, 20 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 6, 2026.

The request: Watch Teva Pharmaceuticals, Inc. (FDA labeler code 0480): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0480
Products in commercial distribution
176
Packages
203
Finished drugs by generic name
60
Prescription products
155
Over the counter products
1
Controlled substance products
Schedule II 23, Schedule III 6, Schedule IV 8
Flagged as original packager
137 of 137 products that carry the flag
Started marketing in the last 12 months
44
Products with a marketing end date set
10
Earliest marketing start
December 15, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)14683%
Drugs for further processing2011.4%
New drug applications (NDA)84.5%
Authorized generics (NDA)21.1%

Products by type

TypeProductsShare
Prescription drugs15588.1%
Drugs for further processing2011.4%
Over the counter drugs10.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated5330.1%
Capsule2514.2%
Capsule, extended release2011.4%
Tablet2011.4%
Kit148%
Tablet, orally disintegrating63.4%
Tablet, chewable63.4%
Capsule, gelatin coated42.3%
Tablet, delayed release31.7%
Capsule, liquid filled31.7%
Solution, concentrate31.7%
Tablet, film coated, extended release31.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Hydrochlorothiazide0480-3444TabletGeneric drugs (ANDA)October 6, 2026
Eltrombopag0480-4210Tablet, film coatedGeneric drugs (ANDA)September 17, 2026
Eltrombopag0480-4031Tablet, film coatedGeneric drugs (ANDA)September 17, 2026
Eltrombopag0480-4015Tablet, film coatedGeneric drugs (ANDA)September 17, 2026
Eltrombopag0480-2600Tablet, film coatedGeneric drugs (ANDA)September 17, 2026
Dextromethorphan hydrobromide and quinidine sulfate0480-2602CapsuleGeneric drugs (ANDA)September 16, 2026
Tolvaptan0480-3414KitGeneric drugs (ANDA)August 27, 2026
Tolvaptan0480-3314KitGeneric drugs (ANDA)August 27, 2026
Tolvaptan0480-3313KitGeneric drugs (ANDA)August 27, 2026
Tolvaptan0480-3312KitGeneric drugs (ANDA)August 27, 2026
Tolvaptan0480-3311KitGeneric drugs (ANDA)August 27, 2026
Tolvaptan0480-5484TabletDrugs for further processingJuly 21, 2026
Tolvaptan0480-5483TabletDrugs for further processingJuly 21, 2026
Tolvaptan0480-5482TabletDrugs for further processingJuly 21, 2026
Tolvaptan0480-5481TabletDrugs for further processingJuly 21, 2026
Tolvaptan0480-5480TabletDrugs for further processingJuly 21, 2026
Gabapentin0480-3496CapsuleGeneric drugs (ANDA)July 9, 2026
Atorvastatin Calcium0480-3585Tablet, film coatedGeneric drugs (ANDA)June 10, 2026
Macitentan0480-0915Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Atorvastatin Calcium0480-3587Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Atorvastatin Calcium0480-3586Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Sitagliptin0480-2609Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Sitagliptin0480-2608Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Sitagliptin0480-2607Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Budesonide and formoterol fumarate dihydrate0480-3081Aerosol, meteredGeneric drugs (ANDA)May 27, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.